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Unknown ethiology
Brugada phenocopies (BrP) are clinical and electrocardiographic (ECG) entities elicited by reversible medical
conditions speculated to have pathogenesis rooted in ion current imbalances or conduction delays within the
myocardial wall. During an inciting pathologic condition, it produces ECG patterns identical to those of congenitally-acquired Brugada syndrome and subsequently returns to normal ECG patterns upon resolution of the
medical condition. This case report describes a 26-year-old man presenting to the Emergency Department (ED)
for suspected heroin overdose with a rare ECG consistent with BrP secondary to acute hyperkalemia.
A 26-year-old man with a history of substance abuse and a seizure disorder presented to the ED for acute
encephalopathy secondary to a heroin overdose complicated by severe rhabdomyolysis and acute renal failure. Laboratory investigations showed acute hyperkalemia (potassium of 7.2 mmol/L) in addition to an elevated creatine kinase, severe transaminitis, and elevated creatinine. His ECG on admission revealed Brugada-like
changes in leads V1-V2, with subsequent resolution upon bicarbonate administration and normalization of potassium. After initial stabilization, the patient was admitted to the Intensive Care Unit (ICU). His rhabdomyolysis and acute kidney injury improved after copious rehydration. He was found to have community-acquired
pneumonia, with a negative infectious disease workup, that improved with antibiotics. Upon resolution of his
hypoxemic respiratory failure and improvement in mentation, he was discharged from the hospital.
Our case report adds to the growing literature on BrP and highlights the importance of recognizing its characteristic ECG pattern as a unique presentation of a common electrolyte derangement.
Brugada Syndrome • Drug Overdose • Hyperkalemia
https://www.amjcaserep.com/abstract/index/idArt/923464
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Background

Case Report

Interest in understanding the ionic channel dysfunction,
arrhythmogenic potential, diagnosis, and treatment of Brugada
phenocopies has grown markedly since the characterization
of the condition in 2012 [1]. Identical to congenital Brugada
syndrome, the ECG patterns characterizing BrP can be classiﬁed into 2 patterns: the typical type 1 “coved” and the type 2
“saddleback” [2,3]. Over 100 cases have been reported in the
medical literature, with causative medical conditions falling
into 6 general categories: (1) metabolic abnormalities, (2) mechanical compression, (3) ischemia and pulmonary embolism,
(4) myocardial and pericardial disease, (5) ECG modulation, and
(6) miscellaneous (electrical injury, Ebstein’s anomaly). Of these
causes, metabolic derangements are the most common. One
speciﬁc electrolyte disturbance, hyperkalemia, causes a multitude of ECG changes ranging from peaked T waves to sine
waves. However, knowledge of its association with the Brugada
pattern continues to grow. Here, we supplement the mounting
number of cases detailing hyperkalemia as the driver of the
reversible electrocardiographic phenomenon known as BrP.

A 26-year-old man with a history of cocaine and heroin abuse,
as well as a seizure disorder, was brought to the ED by
Emergency Medical Services (EMS) after being found lying
down and unresponsive for approximately 10 hours due to
an apparent overdose. EMS stated that the patient was found
hypoxic, with an oxygen saturation of 68%, which improved
to 95% on Venturi-mask. Both intranasal and IV Narcan were
given, without success. On arrival to the ED, pertinent subjective information, including a personal history of syncope or
family history of sudden cardiac death, was unable to be obtained because the patient was obtunded. Arousing on occasion and responding to noxious stimuli, there was a possibility of previous seizure activity and being post-ictal. A bolus
of Levetiracetam was given and a head CT was done, revealing no acute changes. Vitals showed a temperature of 99.1°F
(37.2°C), heart rate of 106 beats per minute, blood pressure
116/78 mmHg, respiratory rate of 19 breaths per minute, and
an oxygen saturation of 95% on Venturi-mask. ECG showed a
type 1 Brugada pattern in leads aVR, V1, and V2, which normalized after administering sodium bicarbonate (Figure 1).

Figure 1. Electrocardiogram (ECG) tracing in a 26-year-old male presenting with acute encephalopathy, acute hypoxic respiratory
failure, and acute hyperkalemia, resulting in Brugada-like ECG changes. Top ECG tracing obtained while serum potassium
measured 7.2 mmol/L, demonstrating the type 1 “coved” Brugada pattern with concave, ST-segment elevation most
prominent in leads V1 and V2 (arrow). Bottom ECG tracing demonstrating resolution of ST-segment changes after correction
of serum potassium to 4.4 mmol/L.
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Laboratory studies revealed a myriad of derangements,
including: acute hyperkalemia (potassium of 7.2 mmol/L) and
elevated creatine kinase (29,270 units/L on admit with maximum of 74,750 units/L) thought to be secondary to drug overdose-related crush myopathy, and transaminase elevation (AST
4,052 units/L ALT 5,960 units/L) thought to be secondary to
shock liver vs. rhabdomyolysis itself. Repeat potassium was
4.4 mmol/L after administration of calcium gluconate, insulin, glucose, and sodium bicarbonate. Additionally, lactate
levels were elevated at 3.5 mmol/L, venous blood gas was
7.33/35 mmHg/61 mmHg/18 mmol/L consistent with anion
gap acidosis, and creatinine above 3 mg/dL suggesting acute
kidney injury, which improved following ﬂuid supplementation. Urine drug screening performed in the ED was positive
for Levetiracetam, Fentanyl, and Norfentanyl.
After initial stabilization, the patient was admitted to the ICU
still requiring Venturi-mask secondary to his mental status and
acute hypoxic respiratory failure. Collateral history was obtained from the patient’s family and was signiﬁcant for chest
discomfort, diaphoresis, and a dry scratchy throat for 1 week
prior to presentation. Hyperkalemia protocols were initiated
and normalized the potassium level to 3.9 mmol/L. His rhabdomyolysis and acute kidney injury resolved with vigorous hydration that restored his kidney function to baseline. He was
noted to have community-acquired pneumonia with a negative infectious workup (negative blood cultures, negative urinary Streptococcus pneumoniae and Legionella antigens, and
negative respiratory viral panel) for which he ﬁnished a course
of Azithromycin and Ceftriaxone, resulting in resolution of
hypoxia. The patient’s mentation improved, and he was discharged from the hospital.

Discussion
Hyperkalemia causes ECG alterations, including tall, peaked,
and tented T waves, widened and ﬂattened P waves, widening
of the QRS complex, AV blocks, sine wave rhythms, and asystole. However, presentation with coved ST-segment elevation
representing a Brugada pattern is uncommon. In our case, the
etiology of hyperkalemia causing Brugada-like changes was
likely multifactorial, indicating a combination of rhabdomyolysis, acidosis, and acute renal failure, resulting in increased potassium release from muscle breakdown, transcellular shifts,
and impaired excretion. Rapid treatment with calcium gluconate, insulin, and sodium bicarbonate resulted in ECG normalization, likely reﬂecting an improvement in both hyperkalemia and acidemia. Levetiracetam, which inhibits N-type
calcium channels and delayed rectiﬁer potassium currents, was
administered, but this took place after the initial ECG showing Brugada-like changes, and thus was probably not an important contributing factor. The transient nature of the ECG
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alteration is a hallmark in diﬀerentiating Brugada syndrome
from Brugada phenocopy [4].
The congenitally-acquired channelopathy known as Brugada
syndrome (BrS) and the reversible conditions leading to Brugada
phenocopy diﬀer in many clinically relevant ways. BrS is an
autosomal dominant disorder that predisposes patients to lethal arrhythmias and sudden cardiac death without identiﬁable
structural abnormalities. The most common cause is inheriting
one of the approximately 290 pathogenic variants that have
been identiﬁed in the SCN5A gene, which encodes for a speciﬁc cardiac sodium channel. Nevertheless, many other genes
can cause the disorder, including genes coding for subunits
of sodium channels or other ionic channels [5]. This locus and
allelic heterogeneity account for the variable penetrance associated with BrS. Two-thirds of patients are asymptomatic
at diagnosis, while one-third are identiﬁed after non-speciﬁc
symptomatology (e.g., syncope and aborted sudden cardiac
death). Once a patient is identiﬁed and risk-stratiﬁed according to risk of sudden cardiac death, a complex management
begins. However, the only proven eﬀective therapy is implantation of an implantable cardioverter device (ICD) to terminate
lethal arrhythmias. Recently, ablation of the arrhythmic electrophysiological substrate (AES), purported to be in the epicardium of the right ventricular anterior wall and outﬂow tract,
has been suggested as a possible therapeutic option resulting in correction of ECG abnormalities [5,6].
The causes and management strategies mentioned above for
BrS diﬀer signiﬁcantly from those for BrP. The proposed pathogenesis of these reversible Brugada-like patterns is largely described by two theories. The repolarization theory describes ion
current imbalances during phase 1 of the myocyte action potential in which partial repolarization occurs as the precluding
abnormality. Speciﬁcally, an increased transient outward potassium current (Ito) or decreased inward currents, either through
L-type calcium currents or peak sodium currents, create focal
ionic imbalances that give rise to reentry arrhythmias [7–10].
Alternatively, the depolarization theory describes a focus in the
right ventricular outﬂow tract that undergoes delayed depolarization and establishes an electrical gradient for the rest of
the right ventricular circuitry, creating a dysrhythmia [7–10].
More recent studies using simulations of the anterior ventricular wall showed that potassium concentration, ﬁbrosis, and Ito
are all involved the development of the Brugada pattern and
act synergistically to shape the characteristic pattern [11]. As
presented in our case, high levels of extracellular potassium
lead to an increase in the normal resting membrane potential
and subsequent inactivation of the sodium channels and delayed conduction. The subsequent creation of ionic imbalances lends support to repolarization as the driver of ECG changes in our case. Nevertheless, much of the current speculation
is based on studies from BrS due to the relative rarity of BrP
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and lack of animal models. Furthering the distinction between
BrS and BrP, there are no data showing an increase in the risk
of SCD in those with BrP; therefore, treatment should focus
on amelioration of the underlying condition rather than cardioverter-deﬁbrillator implantation.

Conclusions
The diﬀerences between Brugada syndrome and Brugada phenocopy shed light on both the challenge and importance of an
accurate diagnosis of BrP in providing appropriately tailored
therapy. It has been well documented that the hyperkalemicinduced Brugada pattern carries a grim prognosis [12]. Thus,
we hope that our case report increases awareness and recognition of a rare presentation of a common electrolyte disorder.
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